Titan Pharmaceuticals

Titan Pharmaceuticals company information, Employees & Contact Information

Titan Pharmaceuticals Inc. is developing proprietary therapeutics primarily for the treatment of serious medical disorders. The company's lead product is Probuphine®, the first and only commercialized treatment of opioid dependence to provide continuous, around-the-clock blood levels of buprenorphine for six months following a single procedure. It was approved by the U.S. Food and Drug Administration in May 2016 and is being commercialized in the U.S. by partner Braeburn Pharmaceuticals. Probuphine employs Titan's proprietary drug delivery system ProNeura™, which is capable of delivering sustained, consistent levels of medication for up to 12 months. The ProNeura technology has the potential to be used in developing products for treating other chronic conditions such as Parkinson's disease and hypothyroidism, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Company Details

Employees
31
Founded
-
Address
400 Oyster Point Boulevard, Ste. 505, South San Francisco,california 94080,united States
Phone
6502440715
Email
bu****@****arm.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
South San Francisco, California
Looking for a particular Titan Pharmaceuticals employee's phone or email?

Titan Pharmaceuticals Questions

News

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewswire

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. GlobeNewswire

Titan Pharmaceuticals Completes Private Placement of Series C Convertible Preferred Stock with Blue Harbour Asset Management - Quiver Quantitative

Titan Pharmaceuticals Completes Private Placement of Series C Convertible Preferred Stock with Blue Harbour Asset Management Quiver Quantitative

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - Stock Titan

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. Stock Titan

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock - GlobeNewswire

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock GlobeNewswire

Titan Pharmaceuticals Announces Filing of Registration - GlobeNewswire

Titan Pharmaceuticals Announces Filing of Registration GlobeNewswire

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq - GlobeNewswire

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq GlobeNewswire

Titan Pharmaceuticals Announces Appointment of Dato' Seow - GlobeNewswire

Titan Pharmaceuticals Announces Appointment of Dato' Seow GlobeNewswire

Top Titan Pharmaceuticals Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant